lincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial–mesenchymal transition

Hepatology Research

Volumn 46, Issue 11, 2016, Pages 1137-1144

  Jia, Meng ^a   Jiang, Li ^a   Wang, Ya Dong ^a   Huang, Jin Zhao ^a   Yu, Miao ^a   Xue, Huan Zhou ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

epithelial mesenchymal transition; hepatocellular carcinoma; long non coding RNA; notch

Indexed keywords

BETA CATENIN; CATENIN; HISTONE H3; LONG UNTRANSLATED RNA; NOTCH RECEPTOR; PROTEIN P21;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; GENETIC TRANSFECTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; XENOTRANSPLANTATION;

EID: 85027922521     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12659     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
2. Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 2014; 63: 844–55.
3. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674–87.
4. Gao J, Xie L, Yang W-S, et al. Risk factors of hepatocellular carcinoma-current status and perspectives. Asian Pac J Cancer Prev 2012; 13: 743–52.
5. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178–96.
6. Fan L, Shiau C, Tai W, et al. SHP-1 is a negative regulator of epithelial–mesenchymal transition in hepatocellular carcinoma. Oncogene 2015; 34: 5252–63.
7. Kim HS, Lee KS, Bae HJ, et al. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. Oncotarget 2015; 6: 8089–102.
8. Cheng J, Li M, Lv Y. Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma. Hepatology 2014; 59: 1650.
9. Mikulits W. Epithelial to mesenchymal transition in hepatocellular carcinoma. Future Oncol (London, England) 2009; 5: 1169–79.
10. Kunnimalaiyaan S, Sokolowski K, Balamurugan M, Gamblin T, Kunnimalaiyaan M. Xanthohumol inhibits notch signaling and induces apoptosis in hepatocellular carcinoma. PLoS One 2014; 10: e0127464-e.
11. Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther 2014; 141: 140–9.
12. Villanueva A, Alsinet C, Yanger K, et al. Notch Signaling is Activated in Human Hepatocellular Carcinoma and Induces Tumor Formation in Mice. Gastroenterology 2012; 143: 1660–9.e7.
13. Zhao ZL, Ma SR, Wang WM, et al. Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma. Am J Transl Res 2015; 7: 162–74.
14. Yoon JH, Abdelmohsen K, Srikantan S, et al. LincRNA-p21 suppresses target mRNA translation. Mol Cell 2012; 47: 648–55.
15. Wang J, Lei ZJ, Guo Y, et al. miRNA-regulated delivery of lincRNA-p21 suppresses beta-catenin signaling and tumorigenicity of colorectal cancer stem cells. Oncotarget 2015; 6: 37852–70.
16. Wang G, Li Z, Zhao Q, et al. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/beta-catenin signaling pathway. Oncol Rep 2014; 31: 1839–45.
17. Yang P-M, Lin P-J, Chen C-C. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1. Epigenetics 2012; 7: 390–9.
18. Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 2014; 15: 7–21.
19. Koch L. Disease genetics: Therapeutic targeting of a long non-coding RNA. Nat Rev Genet 2015; 16: 2.
20. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 10: 38–55.
21. Sun J, Bie B, Zhang S, Yang J, Li Z. Long non-coding RNAs: critical players in hepatocellular carcinoma. Int J Mol Sci 2014; 15: 20434–48.
22. Wang Z, Maeda S, Ca L, Karin M, Edgington T. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007; 26: 851–8.
23. Yang N, Fu Y, Zhang H, Sima H, Zhu N, Yang G. LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma. Oncotarget 2015; 6: 28151–63.
24. Zhai H, Fesler A, Schee K, Fodstad Ø, Flatmark K, Ju J. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin Colorectal Cancer 2013; 12: 261–6.
25. Isin M, Uysaler E, Ozgur E, et al. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front Genet 2015; 6: 168.
26. Hall JR, Messenger ZJ, Tam HW, Phillips SL, Recio L, Smart RC. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes. Cell Death Dis 2015; 6: e1700.
27. Blume CJ, Hotz-Wagenblatt A, Hullein J, et al. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia 2015; 29: 2015–23.
28. Yang F, Zhang H, Mei Y, Wu M. Reciprocal regulation of HIF-1alpha and lincRNA-p21 modulates the Warburg effect. Mol Cell 2014; 53: 88–100.
29. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871–90.
30. Biddle A, Mackenzie IC. Cancer stem cells and EMT in carcinoma. Cancer Metastasis Rev 2012; 31: 285–93.
31. Levayer R, Lecuit T. Breaking down EMT. Nat Cell Biol 2008; 10: 757–9.
32. Kofler NM, Shawber CJ, Kangsamaksin T, Reed HO, Galatioto J, Kitajewski J. Notch Signaling in Developmental and Tumor Angiogenesis. Genes Cancer 2011; 2: 1106–16.
33. Groeneweg JW, Foster R, Growdon WB, Verheijen RH, Rueda BR. Notch signaling in serous ovarian cancer. J Ovarian Res 2014; 7: 95.
34. Ntziachristos P, Lim JS, Sage J, Aifantis I. From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling. Cancer Cell 2014; 25: 318–34.
35. Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer 2009; 8: 128.
36. Collu GM, Brennan K. Cooperation between Wnt and Notch signalling in human breast cancer. Breast Cancer Res 2007; 9: 105.
37. Chen X, Xiao W, Liu X, et al. Blockade of Jagged/Notch pathway abrogates transforming growth factor beta2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells. Curr Mol Med 2014; 14: 523–34.